Home LiteratureArticle Details
PMID: 18385397 Published · ppublish English Case Reports Journal Article

Ultrastructural evidence of dermal gadolinium deposits in a patient with nephrogenic systemic fibrosis and end-stage renal disease.

Clinical journal of the American Society of Nephrology : CJASN ·Vol. 3 ·No. 4 ·2008-07-00 ·Pages 968-75

Schroeder JA, Weingart C, Coras B, Hausser I, Reinhold S, Mack M, Seybold V, Vogt T, Banas B, Hofstaedter F, Krämer BK

Abstract

The pathogenesis of acquired nephrogenic systemic fibrosis recently described for patients with renal insufficiency and a history of exposition to gadolinium-based magnetic resonance contrast agents is not completely understood. A role for circulating fibroblasts in the fibrosing tissue is hypothetical, and the mechanism of the assumed trigger function of gadolinium remains elusive. A skin lesion on a 76-yr-old man with symptoms of nephrogenic systemic fibrosis lasting 5 mo was studied at the ultrastructural level. After confirmation of he diagnosis by histopathologic methods, the presence and distribution of gadolinium, iron, calcium, and magnesium by energy filtering transmission electron microscopy was also examined. The performed electron spectroscopic imaging and electron energy loss spectroscopic analyses on deparaffinized samples revealed deposition of gadolinium in irregular small aggregates that adhered to cell profiles and collagen fibers of the connective tissue, forming a perivascular "gadolinium-deposit zone" in the skin. Traces of iron signal were demonstrated in singular gadolinium-positive deposits, and iron presence was found in adjacent connective tissue. The ultrastructural cell analysis of the lesion showed among numerous poorly differentiated fibrocytes also higher differentiated cells with myofibroblastic characteristics, including bundles of intermediate filaments and attachment plaques in the cell periphery, indicating an ability of lesional fibroblasts to differentiate into myofibroblastic cells. These findings support the pivotal role of gadolinium chelates in the development of nephrogenic systemic fibrosis.

MeSH Terms
Aged Calcium/analysis Cell Differentiation Contrast Media/adverse effects Dermis/chemistry,ultrastructure Fibroblasts/chemistry,ultrastructure Fibrosis Gadolinium/analysis Gadolinium DTPA/adverse effects Humans Iron/analysis Kidney Failure, Chronic/complications,pathology,therapy Magnesium/analysis Male Microscopy, Electron, Transmission Microscopy, Energy-Filtering Transmission Electron Skin Diseases/etiology,pathology Spectroscopy, Electron Energy-Loss
Chemicals
Contrast Media Gadolinium Iron Magnesium Gadolinium DTPA Calcium
Authors & Affiliations
11 authors, click to expand affiliations / ORCID
Schroeder Josef A
Klinik und Poliklinik für Innere, Medizin II-Nephrologie, University of Regensburg, Franz-Josef-Strauss-Allee 11, 93053 Regensburg, Germany.
Weingart Christian
Coras Brigitte
Hausser Ingrid
Reinhold Stephan
Mack Matthias
Seybold Volker
Vogt Thomas
Banas Bernhard
Hofstaedter Ferdinand
Krämer Bernhard K
References (52)
52 references, click to expand
  1. Description of 12 cases of nephrogenic fibrosing dermopathy and review of the literature.
    Semin Arthritis Rheum. 2006 Feb;35(4):238-49 PMID: 16461069
  2. Gadolinium is quantifiable within the tissue of patients with nephrogenic systemic fibrosis.
    J Am Acad Dermatol. 2007 Apr;56(4):710-2 PMID: 17289213
  3. Nephrogenic fibrosing dermopathy associated with exposure to gadolinium-containing contrast agents--St. Louis, Missouri, 2002-2006.
    MMWR Morb Mortal Wkly Rep. 2007 Feb 23;56(7):137-41 PMID: 17318112
  4. Gadolinium is not the only trigger for nephrogenic systemic fibrosis: insights from two cases and review of the recent literature.
    Am J Transplant. 2007 Oct;7(10):2425-32 PMID: 17711550
  5. [Nephrogenic systemic fibrosis after application of gadolinium-based contrast agents--a status paper].
    Rofo. 2007 Jun;179(6):613-7 PMID: 17497597
  6. Risk factors for developing gadolinium-induced nephrogenic systemic fibrosis.
    Ann Pharmacother. 2007 Sep;41(9):1481-5 PMID: 17684032
  7. Gadolinium and nephrogenic systemic fibrosis.
    Kidney Int. 2007 Aug;72(3):260-4 PMID: 17507905
  8. Ultrastructural telepathology--remote EM-diagnostic via Internet.
    Ultrastruct Pathol. 2001 Jul-Aug;25(4):301-7 PMID: 11577775
  9. New developments in electron energy loss spectroscopy.
    Microsc Res Tech. 2007 Mar;70(3):211-9 PMID: 17279511
  10. Scleromyxoedema-like cutaneous diseases in renal-dialysis patients.
    Lancet. 2000 Sep 16;356(9234):1000-1 PMID: 11041404
  11. Nephrogenic fibrosing dermopathy.
    Clin Exp Dermatol. 2004 May;29(3):258-60 PMID: 15115505
  12. Gadolinium--a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?
    Nephrol Dial Transplant. 2006 Apr;21(4):1104-8 PMID: 16431890
  13. Multiorgan involvement in nephrogenic fibrosing dermopathy: an autopsy case and review of the literature.
    Arch Pathol Lab Med. 2006 Feb;130(2):209-12 PMID: 16454565
  14. [Nephrogenic systemic fibrosis: more hard times for renal failure patients].
    Nephrol Ther. 2007 Jul;3(4):152-6 PMID: 17658442
  15. Nephrogenic fibrosing dermopathy.
    Am J Dermatopathol. 2001 Oct;23(5):383-93 PMID: 11801769
  16. The relationship between thermodynamics and the toxicity of gadolinium complexes.
    Magn Reson Imaging. 1990;8(4):467-81 PMID: 2118207
  17. New insights into nephrogenic systemic fibrosis.
    J Am Soc Nephrol. 2007 Oct;18(10):2636-43 PMID: 17855637
  18. Electron microscopic detection of tin accumulation in biliopancreatic concrements after induction of chronic pancreatitis in rats by di-n-butyltin dichloride.
    Ultrastruct Pathol. 2002 Mar-Apr;26(2):89-98 PMID: 12036097
  19. Automated scanning electron microscopy and x-ray microanalysis for in situ quantification of gadolinium deposits in skin.
    J Electron Microsc (Tokyo). 2007 Oct;56(5):181-7 PMID: 17951398
  20. Nephrogenic systemic fibrosis (nephrogenic fibrosing dermopathy).
    Curr Opin Rheumatol. 2006 Nov;18(6):614-7 PMID: 17053507
  21. Biological electron energy loss spectroscopy in the field-emission scanning transmission electron microscope.
    Scanning Microsc Suppl. 1994;8:245-58; discussion 258-9 PMID: 7638490
  22. Interaction of fine particles and nanoparticles with red blood cells visualized with advanced microscopic techniques.
    Environ Sci Technol. 2006 Jul 15;40(14):4353-9 PMID: 16903270
  23. Electron energy loss spectroscopic imaging in biology.
    Scanning Microsc. 1988 Mar;2(1):257-66 PMID: 3285454
  24. New techniques in electron energy-loss spectroscopy and energy-filtered imaging.
    Micron. 2003;34(3-5):127-39 PMID: 12895484
  25. Gadolinium deposition in nephrogenic fibrosing dermopathy.
    J Am Acad Dermatol. 2007 Jan;56(1):27-30 PMID: 17109993
  26. Cutaneous changes of nephrogenic systemic fibrosis: predictor of early mortality and association with gadolinium exposure.
    Arthritis Rheum. 2007 Oct;56(10):3433-41 PMID: 17907148
  27. Nephrogenic fibrosing dermopathy: a novel cutaneous fibrosing disorder in patients with renal failure.
    Am J Med. 2003 May;114(7):563-72 PMID: 12753880
  28. Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells.
    Environ Health Perspect. 2005 Nov;113(11):1555-60 PMID: 16263511
  29. The myofibroblast: a study of normal, reactive and neoplastic tissues, with an emphasis on ultrastructure.
    J Submicrosc Cytol Pathol. 2007;:7-166 PMID: 18277533
  30. Nephrogenic systemic fibrosis after exposure to gadolinium in patients with renal failure.
    Nephrol Dial Transplant. 2007 Nov;22(11):3179-85 PMID: 17890246
  31. Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury.
    Circulation. 2002 Jan 15;105(2):224-9 PMID: 11790705
  32. Involvement of skeletal muscle in dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy).
    Muscle Nerve. 2004 Nov;30(5):569-77 PMID: 15389718
  33. Ultrastructural detection of calcium and magnesium in the chromatoid body of mouse spermatids by electron spectroscopic imaging and electron energy loss spectroscopy.
    J Histochem Cytochem. 1993 Aug;41(8):1155-62 PMID: 8331281
  34. Long-term retention of gadolinium in tissues from nephrogenic systemic fibrosis patient after multiple gadolinium-enhanced MRI scans: case report and implications.
    Contrast Media Mol Imaging. 2007 Jul;2(4):199-205 PMID: 17712863
  35. Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis.
    J Am Acad Dermatol. 2007 Jan;56(1):21-6 PMID: 17097388
  36. Copper accumulation in actinomyces druses during endometritis after long-term use of an intrauterine contraceptive device.
    Ultrastruct Pathol. 2002 Sep-Oct;26(5):323-9 PMID: 12396243
  37. Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma.
    J Immunol. 2003 Jul 1;171(1):380-9 PMID: 12817021
  38. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis--setting the record straight.
    Semin Arthritis Rheum. 2006 Feb;35(4):208-10 PMID: 16461067
  39. Acute renal failure and myalgia in a transplant patient.
    J Am Soc Nephrol. 2007 Nov;18(11):2870-4 PMID: 17942960
  40. Cytochemical energy-filtering transmission electron microscopy of mitochondrial free radical formation in paraquat cytotoxicity.
    J Electron Microsc (Tokyo). 1999;48(3):289-96 PMID: 10425747
  41. Nephrogenic fibrosing dermopathy in a renal transplant recipient with tubulointerstitial nephritis and uveitis.
    Dermatology. 2004;209(1):50-2 PMID: 15237268
  42. Circulating fibrocytes: collagen-secreting cells of the peripheral blood.
    Int J Biochem Cell Biol. 2004 Apr;36(4):598-606 PMID: 15010326
  43. Reaction of gadolinium chelates with endogenously available ions.
    Magn Reson Imaging. 1991;9(3):409-15 PMID: 1881260
  44. Limits to the spatial, energy and momentum resolution of electron energy-loss spectroscopy.
    Ultramicroscopy. 2007 Aug;107(8):575-86 PMID: 17257759
  45. Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: a review.
    Fundam Clin Pharmacol. 2006 Dec;20(6):563-76 PMID: 17109649
  46. Biodistribution and metabolism of targeted and nontargeted protein-chelate-gadolinium complexes: evidence for gadolinium dissociation in vitro and in vivo.
    Magn Reson Imaging. 1995;13(2):201-14 PMID: 7739361
  47. Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging.
    J Am Soc Nephrol. 2006 Sep;17(9):2359-62 PMID: 16885403
  48. Nephrogenic systemic fibrosis and gadolinium exposure: association and lessons for idiopathic fibrosing disorders.
    Arthritis Rheum. 2007 Oct;56(10):3173-5 PMID: 17907160
  49. Possible role of gadolinium in nephrogenic systemic fibrosis: report of two cases and review of the literature.
    Clin Exp Dermatol. 2007 Jul;32(4):353-8 PMID: 17433041
  50. Energy-filtering transmission electron microscopy (EFTEM) in the elemental analysis of pseudoexfoliative material.
    Curr Eye Res. 2001 Feb;22(2):154-62 PMID: 11402393
  51. Electron energy loss spectroscopy for analysis of inhaled ultrafine particles in rat lungs.
    Microsc Res Tech. 2004 Apr 1;63(5):298-305 PMID: 15170760
  52. Gadolinium induces macrophage apoptosis.
    J Leukoc Biol. 1996 Feb;59(2):189-95 PMID: 8603991
Article Info
Journal
Clinical journal of the American Society of Nephrology : CJASN
Abbr.
Clin J Am Soc Nephrol
ISSN
1555-905X
Published
2008-07-00
Epub
2008-00-02
Pages
968-75
Language
English
Region
United States
NLM ID
101271570
PMCID
PMC2440263
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com